AI Breakthrough: Isomorphic Labs' New Drug Design Engine Doubles AlphaFold 3's Accuracy

Google DeepMind's sister company Isomorphic Labs has just unveiled IsoDDE — a groundbreaking AI drug design engine that more than doubles the accuracy of AlphaFold 3, the system that already revolutionised how scientists understand the building blocks of life. IsoDDE doesn't just predict protein structures — it can identify where drugs should bind, forecast how tightly they'll attach, and do it all at a fraction of the time and cost of traditional methods. It's essentially giving scientists a superpower: the ability to design new medicines on a computer with unprecedented precision. What makes this especially exciting is the potential to accelerate treatments for diseases that have stumped researchers for decades. By bridging the gap between predicting molecular structures and actually discovering real-world drugs, IsoDDE could dramatically speed up the journey from lab to pharmacy shelf. Demis Hassabis, CEO of Google DeepMind, called the progress 'incredible work' that is 'extending the state of the art further across key benchmarks.' The future of medicine is being designed by AI — and it's looking very promising indeed.